{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T14:58:18Z","timestamp":1775487498136,"version":"3.50.1"},"reference-count":55,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Buddhist Tzu Chi Medical Foundation, Taiwan","award":["TCRD111-048"],"award-info":[{"award-number":["TCRD111-048"]}]},{"name":"Buddhist Tzu Chi Medical Foundation, Taiwan","award":["TCMF-A 106-01-08"],"award-info":[{"award-number":["TCMF-A 106-01-08"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Sclerostin and dickkopf-1 (DKK1), which are Wnt inhibitors, are involved in vascular calcification and atherosclerosis. Atherosclerotic peripheral artery disease (PAD) is highly prevalent, particularly in patients with hypertension. This study aimed to explore the association between serum concentrations of Wnt pathway inhibitors and PAD in patients with hypertension. Materials and Methods: This cross-sectional trial recruited 92 patients with hypertension. PAD was defined as an ankle-brachial index &lt; 0.9. The levels of sclerostin, DKK1, C-reactive protein (CRP), and other biochemical markers were assessed using fasting blood samples. Univariate and multivariate logistic regression and receiver operating characteristic curve analyses were conducted. Results: Patients with PAD (15.2%) had significantly higher serum sclerostin (p &lt; 0.001) and CRP (p = 0.001) levels than those without PAD. However, the two groups did not significantly differ in terms of the DKK1 levels. Based on the multivariate analysis, sclerostin was an independent predictor of PAD (odds ratio: 1.054 per 1 pmol\/L increase, 95% confidence interval: 1.019\u20131.090, p = 0.002) after adjusting for body mass index, fasting glucose levels, diabetes, smoking, and CRP levels. Sclerostin had a strong discriminatory power for diagnosing PAD according to the receiver operating characteristic curve analysis (area under the curve: 0.806, p &lt; 0.001), with the best cutoff value of 71.5 pmol\/L (sensitivity: 71.4%, specificity: 78.2%). Further, sclerostin was negatively associated with the ankle-brachial index, renal function, and dyslipidemia markers. Conclusions: Serum sclerostin levels are independently related to an increased risk for PAD in patients with hypertension. Therefore, it can be a potential biomarker for risk stratification and early diagnosis.<\/jats:p>","DOI":"10.3390\/medicina61071204","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T05:28:28Z","timestamp":1751347708000},"page":"1204","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Increased Serum Sclerostin Level Is a Risk Factor for Peripheral Artery Disease in Patients with Hypertension"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-3479-0142","authenticated-orcid":false,"given":"Yahn-Bor","family":"Chern","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Yuan\u2019s General Hospital, Kaohsiung 80249, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po-Sheng","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 97004, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Hung","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 97004, Taiwan"},{"name":"Division of Cardiology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 97004, Taiwan"},{"name":"School of Medicine, Tzu Chi University, Hualien 97004, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9405-8649","authenticated-orcid":false,"given":"Jen-Pi","family":"Tsai","sequence":"additional","affiliation":[{"name":"School of Medicine, Tzu Chi University, Hualien 97004, Taiwan"},{"name":"Division of Nephrology, Department of Internal Medicine, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi 62247, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9364-4558","authenticated-orcid":false,"given":"Bang-Gee","family":"Hsu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 97004, Taiwan"},{"name":"School of Medicine, Tzu Chi University, Hualien 97004, Taiwan"},{"name":"Division of Nephrology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 97004, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1161\/HYPERTENSIONAHA.119.14240","article-title":"High blood pressure and cardiovascular disease","volume":"75","author":"Fuchs","year":"2020","journal-title":"Hypertension"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Poznyak, A.V., Sadykhov, N.K., Kartuesov, A.G., Borisov, E., Melnichenko, A.A., Grechko, A.V., and Orekhov, A.N. (2022). Hypertension as a risk factor for atherosclerosis: Cardiovascular risk assessment. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.959285"},{"key":"ref_3","unstructured":"Fryar, C.D., Kit, B., Carroll, M.D., and Afful, J. (2025, May 14). Key Findings Data from the National Health and Nutrition Examination Survey, Available online: https:\/\/www.cdc.gov\/nchs\/products\/index.htm."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e032527","DOI":"10.1161\/JAHA.123.032527","article-title":"Trends and disparities in treatment and control of atherosclerotic cardiovascular disease in US adults, 1999 to 2018","volume":"13","author":"Li","year":"2024","journal-title":"J. Am. Heart Assoc."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e1020","DOI":"10.1016\/S2214-109X(19)30255-4","article-title":"Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: An updated systematic review and analysis","volume":"7","author":"Song","year":"2019","journal-title":"Lancet Glob. Health"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","article-title":"Heart disease and stroke statistics-2022 Update: A report from the American Heart Association","volume":"145","author":"Tsao","year":"2022","journal-title":"Circulation"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jvs.2022.12.015","article-title":"The global burden of peripheral artery disease","volume":"77","author":"Eid","year":"2022","journal-title":"J. Vasc. Surg."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1177\/2047487313519344","article-title":"Peripheral artery disease is a coronary heart disease risk equivalent among both men and women: Results from a nationwide study","volume":"22","author":"Subherwal","year":"2015","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.atherosclerosis.2019.09.012","article-title":"Morbidity and mortality associated with atherosclerotic peripheral artery disease: A systematic review","volume":"293","author":"Agnelli","year":"2020","journal-title":"Atherosclerosis"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Curcio, A., Panarello, A., Spaccarotella, C., and Indolfi, C. (2023). Cardiovascular prognosis in patients with peripheral artery disease and approach to therapy. Biomedicines, 11.","DOI":"10.3390\/biomedicines11123131"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1097\/HJH.0000000000003195","article-title":"WNT1-inducible signalling pathway protein 1 stabilizes atherosclerotic plaques in apolipoprotein-E-deficient mice via the focal adhesion kinase\/mitogen-activated extracellular signal-regulated kinase\/extracellular signal-regulated kinase pathway","volume":"4","author":"Liu","year":"2022","journal-title":"J. Hypertens."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Afroz, R., and Goodwin, J.E. (2024). Wnt signaling in atherosclerosis: Mechanisms to therapeutic implications. Biomedicines, 12.","DOI":"10.3390\/biomedicines12020276"},{"key":"ref_13","first-page":"519","article-title":"Wnt signaling pathway and sclerostin in the development of atherosclerosis and vascular calcification","volume":"33","author":"Chudek","year":"2024","journal-title":"Adv. Clin. Exp. Med."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Khan, K., Yu, B., Tardif, J.C., Rh\u00e9aume, E., Al-Kindi, H., Filimon, S., Pop, C., Genest, J., Cecere, R., and Schwertani, A. (2024). Significance of the Wnt signaling pathway in coronary artery atherosclerosis. Front. Cardiovasc. Med., 11.","DOI":"10.3389\/fcvm.2024.1360380"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/34848","article-title":"Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction","volume":"391","author":"Glinka","year":"1998","journal-title":"Nature"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"19883","DOI":"10.1074\/jbc.M413274200","article-title":"Sclerostin binds to LRP5\/6 and antagonizes canonical Wnt signaling","volume":"280","author":"Li","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1161\/ATVBAHA.109.189761","article-title":"Dickkopf-1 enhances inflammatory interaction between platelets and endothelial cells and shows increased expression in atherosclerosis","volume":"29","author":"Ueland","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.atherosclerosis.2011.05.015","article-title":"Circulating dickkopf-1 in acute ischemic stroke and clinically stable cerebrovascular disease","volume":"218","author":"Pekar","year":"2011","journal-title":"Atherosclerosis"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.atherosclerosis.2016.08.003","article-title":"High serum levels of sclerostin and dickkopf-1 are associated with acute ischaemic stroke","volume":"253","author":"He","year":"2016","journal-title":"Atherosclerosis"},{"key":"ref_20","first-page":"2816","article-title":"Serum sclerostin as an independent marker of peripheral artery disease in elderly persons","volume":"11","author":"Teng","year":"2018","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1161\/ATVBAHA.122.317635","article-title":"Role of sclerostin in cardiovascular Disease","volume":"42","author":"Golledge","year":"2022","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Chen, Y.L., Huang, P.Y., Tsai, J.P., Wang, J.S., and Hsu, B.G. (2023). Serum osteoprotegerin levels and the vascular reactivity index in patients with hypertension. Medicina, 59.","DOI":"10.3390\/medicina59101794"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Wang, Y.H., Hsiao, C.H., Wang, J.S., and Hsu, B.G. (2024). Osteocalcin: A potential marker of peripheral arterial stiffness in hypertensive patients. Medicina, 60.","DOI":"10.3390\/medicina60050835"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e3300","DOI":"10.1097\/MD.0000000000003300","article-title":"Serum sclerostin as an independent marker of peripheral arterial stiffness in renal transplantation recipients: A cross-sectional study","volume":"95","author":"Hsu","year":"2016","journal-title":"Medicine"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1177\/1479164118816661","article-title":"Correlation between sclerostin and dickkopf-1 with aortic arterial stiffness in patients with type 2 diabetes: A Prospective, cross-sectional study","volume":"16","author":"Yang","year":"2019","journal-title":"Diab. Vasc. Dis. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1177\/17085381211039941","article-title":"Positive correlation of serum indoxyl sulfate level with peripheral arterial disease in hemodialysis patients","volume":"30","author":"Chiu","year":"2022","journal-title":"Vascular"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"124","DOI":"10.31083\/j.rcm2504124","article-title":"High serum galectin-3 level as a potential biomarker of peripheral artery disease in patients undergoing hemodialysis","volume":"25","author":"Chiu","year":"2024","journal-title":"Rev. Cardiovasc. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3758\/BRM.41.4.1149","article-title":"Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses","volume":"41","author":"Faul","year":"2009","journal-title":"Behav. Res. Methods"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5551\/jat.RV17014","article-title":"Mechanism of development of atherosclerosis and cardiovascular disease in diabetes mellitus","volume":"25","author":"Katakami","year":"2018","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Nedosugova, L.V., Markina, Y.V., Bochkareva, L.A., Kuzina, I.A., Petunina, N., Yudina, I., and Kirichenko, T.V. (2022). Inflammatory mechanisms of diabetes and its vascular complications. Biomedicines, 10.","DOI":"10.3390\/biomedicines10051168"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/s41392-023-01400-z","article-title":"Diabetic vascular diseases: Molecular mechanisms and therapeutic strategies","volume":"8","author":"Li","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2174\/1381612825666191216144055","article-title":"Current position on the role of monomeric C-reactive protein in vascular pathology and atherothrombosis","volume":"26","author":"Melnikov","year":"2019","journal-title":"Curr. Pharm. Des."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1055\/s-0044-1788296","article-title":"Role of C-reactive protein, an inflammatory biomarker in the development of atherosclerosis and its treatment","volume":"33","author":"Prasad","year":"2024","journal-title":"Int. J. Angiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"101","DOI":"10.5051\/jpis.2015.45.3.101","article-title":"Hyperglycemia increases the expression levels of sclerostin in a reactive oxygen species- and tumor necrosis factor-alpha-dependent manner","volume":"45","author":"Kang","year":"2015","journal-title":"J. Periodontal Implant. Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.2337\/dc14-2989","article-title":"Sclerostin and insulin resistance in prediabetes: Evidence of a cross talk between bone and glucose metabolism","volume":"38","author":"Daniele","year":"2015","journal-title":"Diabetes Care"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"115053","DOI":"10.1016\/j.bone.2019.115053","article-title":"Association of serum sclerostin levels with low skeletal muscle mass: The Korean sarcopenic obesity study (KSOS)","volume":"128","author":"Kim","year":"2019","journal-title":"Bone"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1530\/EC-20-0535","article-title":"Serum sclerostin is negatively associated with insulin sensitivity in obese but not lean women","volume":"10","author":"Aznou","year":"2021","journal-title":"Endocr. Connect."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/sdi.12415","article-title":"Sclerostin, osteocytes, and chronic kidney disease\u2014Mineral bone disorder","volume":"28","author":"Schiavi","year":"2015","journal-title":"Semin. Dial."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11914-015-0263-2","article-title":"Sclerostin and CKD-MBD","volume":"13","author":"Schiavi","year":"2015","journal-title":"Curr. Osteoporos. Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s41100-016-0024-4","article-title":"Role of sclerostin in the pathogenesis of chronic kidney disease-mineral bone disorder","volume":"2","author":"Asamiya","year":"2016","journal-title":"Renal Replace. Ther."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Williams, M., White, S.C., Joseph, Z.O., and Hruska, K.A. (2023). Updates in the chronic kidney disease-mineral bone disorder show the role of osteocytic proteins, a potential mechanism of the bone\u2014Vascular paradox, a therapeutic target, and a biomarker. Front. Physiol., 14.","DOI":"10.3389\/fphys.2023.1120308"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Laster, M., Pereira, R.C., Noche, K., Gales, B., Salusky, I.B., and Albrecht, L.V. (2023). Sclerostin, osteocytes, and Wnt signaling in pediatric renal osteodystrophy. Nutrients, 15.","DOI":"10.3390\/nu15194127"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/jdi.12487","article-title":"Re-examining the high-density lipoprotein hypothesis","volume":"7","author":"Tan","year":"2016","journal-title":"J. Diabetes Investig."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Catalano, A., Bellone, F., Morabito, N., and Corica, F. (2020). Sclerostin and vascular pathophysiology. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21134779"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s11255-018-2050-3","article-title":"Relationship between plasma levels of sclerostin, calcium\u2013phosphate disturbances, established markers of bone turnover, and inflammation in haemodialysis patients","volume":"51","author":"Pietrzyk","year":"2019","journal-title":"Int. Urol. Nephrol."},{"key":"ref_46","first-page":"24","article-title":"The hidden cross talk between bone and tissues through bone turnover","volume":"5","year":"2023","journal-title":"Adv. Lab. Med."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Li, Y., Luo, Y., Huang, D., and Peng, L. (2024). Sclerostin as a new target of diabetes-induced osteoporosis. Front. Endocrinol., 15.","DOI":"10.3389\/fendo.2024.1491066"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Li, Y., Gu, Z., Wang, J., Wang, Y., Chen, X., and Dong, B. (2022). The emerging role of bone-derived hormones in diabetes mellitus and diabetic kidney disease. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.938830"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1161\/ATVBAHA.116.308723","article-title":"Wnt signaling pathway inhibitor sclerostin inhibits angiotensin II-induced aortic aneurysm and atherosclerosis","volume":"37","author":"Krishna","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bbrc.2006.06.082","article-title":"Activation of the canonical Wnt\/\u03b2-catenin pathway enhances monocyte adhesion to endothelial cells","volume":"347","author":"Lee","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.devcel.2005.02.017","article-title":"Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation","volume":"8","author":"Glass","year":"2005","journal-title":"Dev. Cell"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1161\/01.RES.0000253139.82251.31","article-title":"\u03b2-catenin nuclear activation: Common pathway between Wnt and growth factor signaling in vascular smooth muscle cell proliferation?","volume":"99","author":"Couffinhal","year":"2006","journal-title":"Circ. Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1242\/dev.02480","article-title":"Distinct roles for hedgehog and caronical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors","volume":"133","author":"Rodda","year":"2006","journal-title":"Development"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41569-019-0239-5","article-title":"Endothelial responses to shear stress in atherosclerosis: A novel role for developmental genes","volume":"17","author":"Souilhol","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/jmcb\/mju036","article-title":"Monocyte-secreted Wnt5a interacts with FZD5 in microvascular endothelial cells and induces angiogenesis through tissue factor signaling","volume":"6","author":"Arderiu","year":"2014","journal-title":"J. Mol. Cell Biol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/7\/1204\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:02:10Z","timestamp":1760032930000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/7\/1204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":55,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["medicina61071204"],"URL":"https:\/\/doi.org\/10.3390\/medicina61071204","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]}}}